Overview

A Study to Evaluate the Long-term Safety and Efficacy of BMS-986165 in Participants With Crohn's Disease or Ulcerative Colitis

Status:
Not yet recruiting

Trial end date:
2027-06-04

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the long-term safety and efficacy of BMS-986165 in participants who have previously been enrolled in a BMS-986165 Phase 2 study for moderate to severe Crohn's disease or moderate to severe Ulcerative Colitis.

Phase:

Phase 2

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

BMS-986165